Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06285851
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2024-01-30
Brief Title:
A Novel Iron Supplement for Athletes Phase I
Sponsor:
University of Calgary
Organization:
University of Calgary
Study Overview
Official Title:
Pilot Study for a Novel Iron-Based Supplement for Athletes
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance This study is a pilot trial to assess the tolerability of a novel iron supplement prior to conducting a clinical trial on the efficacy of the developed novel iron supplement on iron status and performance
Detailed Description:
Current iron supplements on the market are commonly associated with side effects including gastrointestinal distress nausea vomiting and constipation As a solution the investigators have developed a novel delivery system for iron supplementation that overcomes many of these limitations The goal of this study is to assess the tolerability of the developed supplement and any associated symptoms before conducting a clinical trial on this product Participants will consume 40mg of elemental iron every second day for 14 days Participants will complete a daily survey in which they will report feelings of stress and recovery as well as gastrointestinal symptoms Additionally participants will complete a more thorough survey of gastrointestinal symptoms at baseline the mid-point and the end of the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None